Implementing chemometrics in late stage development and manufacturing
2
SHARES
Posted: 26 April 2012 |
Chemometrics was defined as a research area in 1974 and developed rapidly through the following decades in parallel with the fast paced improvement in analytical technologies and computational power for lab instruments and sensors. Chemometrics is essentially the translation of measured signals characterising a sample or a process into meaningful results. This is achieved by applying a number of powerful multivariate data analytical techniques (MVA) to develop a model from a representative data set, and use this model to predict or quantify the property of interest for new samples or process runs.
In the pharmaceutical industry, chemometrics has been successfully applied at every stage from discovery, through development, and to manufacturing. In this review, the requirements and benefits to applying chemometrics in late stage development and manufacturing will be discussed.
Two main areas of interest in pharma – ceutical development and manufacturing are QbD (Quality by Design) and PAT (Process Analytical Technologies), and chemometrics, i.e. modelling, is a key element of these approaches. Chemometrics is used for simplicity as the label for any model translating data into meaningful output in the following discussion. To maximise the benefit from chemometrics, the very first step is to define the objective of the model.
Chemometrics was defined as a research area in 1974 and developed rapidly through the following decades in parallel with the fast paced improvement in analytical technologies and computational power for lab instruments and sensors. Chemometrics is essentially the translation of measured signals characterising a sample or a process into meaningful results. This is achieved by applying a number of powerful multivariate data analytical techniques (MVA) to develop a model from a representative data set, and use this model to predict or quantify the property of interest for new samples or process runs.
This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.
Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.
What you’ll discover:
Key trends shaping the pharmaceutical formulation sector
Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
Can’t attend live? No worries – register to receive the recording post-event.
In the pharmaceutical industry, chemometrics has been successfully applied at every stage from discovery, through development, and to manufacturing. In this review, the requirements and benefits to applying chemometrics in late stage development and manufacturing will be discussed.
Two main areas of interest in pharma – ceutical development and manufacturing are QbD (Quality by Design) and PAT (Process Analytical Technologies), and chemometrics, i.e. modelling, is a key element of these approaches. Chemometrics is used for simplicity as the label for any model translating data into meaningful output in the following discussion. To maximise the benefit from chemometrics, the very first step is to define the objective of the model. This is not unique to chemometrics, but there is a widespread misconception that data of any quality can be analysed and interpreted. To some extent, this is true, but the quality of any findings or conclusions is strongly correlated with the quality of the data. A thorough discussion of data quality is a full review in itself but generically, data should be consistent, relevant and under quality control. Consistency relates to how easily data can be analysed while the relevance relates to how valid any inference from the data will be. Particular attention needs to be paid to the selection of data to be used in the reference set and design of experiments (DoE) is an important tool for this. Quality control is an obvious requirement to ensure that any manually handled data are without typos and any automatically generated data are produced by suitably calibrated and validated systems.
Good quality data can be seen as analyse ready data although additional pre-treatment of the data is usually required before any models can be built. Pre-treatment is understood as data operations which enhance the accessibility to the information of interest in the data and reduce irrelevant features and noise. For spectroscopic data, baseline corrections are typical examples of pre-treatment operations. Scaling of variables to ensure that parameters of different magnitude such as temperature and pressure for instance become comparable is a typical pre-treatment example for process data.
Another important aspect for early planning is that the objective of the project defines the data infrastructure requirements, i.e. the required data systems, data transfer protocols, data flows and storage requirements. If the ambition is to develop a quality control method for use in the laboratory, the infrastructure requirements are very different compared to the objective of developing an online quality control [PAT] method for instance. Companies with ambitions within QbD and PAT should have programs and strategies to deliver the data infrastructure required to support the business ambitions in the area, and if so it is a matter of identifying where the model fits and implement accordingly. Developing QbD and PAT strategies without chemometrics as a key component is a risk as chemometrics is very much the link between measurements and actionable output, i.e. the manufacturing intelligence forming step.
A structured way to work with models in manufacturing is to align model types to the S95 hierarchy which is a standard way of structuring the automation data infrastructure for manufacturing. Adopting this approach simplifies the communication between automation, IT and chemometrics subject matter experts. The S95 levels translate directly into business levels like operational and enterprise so it also becomes easier to assess which business roles need the model outputs and what type of decisions are made by the different models.
The control strategy for manufacturing of a product has a strong influence on the type of model to develop and also the way to present the model output to the user. A model can be used to assess the end product quality by predicting assays from spectra recorded in compression for instance, while another model can monitor the characteristics of input materials using physical properties data. In the first instance the obvious control decision is ‘pass’ or ‘fail’ resulting in accepting or rejecting the tablet, although more advanced use of the model output could be to monitor the closeness to the target assay and to perform precautionary controls if drift or deviation is observed, even if the product is still within the assay limits. In the monitoring of the input materials, the control action is not necessarily ‘pass’ or ‘fail’ but perhaps the materials can be managed to ensure that e.g. the coarser filler is used in products for which this is not a critical quality attribute. Mixing batches of input materials to actively ensure that e.g. the overall size distribution is suitable, is a more advanced control action which can be possible if the right product knowledge is in place.
Whether a company [site] has one model or many models, ownership and use of the models are important questions. Expert skills may be required during development of the model, but it is unlikely that subject matter experts will be available e.g. during manufacturing. This means that any output from the model must be understood by the personnel which is using the model, and this includes both understanding of how to use the results when for example process is on target as well as how to deal with potential deviations or faults. The responsibility sits with the model developer who should ensure that all outputs are self-explanatory, or at least easily grasped by the user group. Models are dynamic and if there are changes to input materials due to change of vendor or seasonal variations for instance, a model assessment is required and potentially also a model update. Additionally, regulatory bodies do require a regular review of models to ensure that the models remain relevant and suitable. The model owner must be able to deal with this type of maintenance operation so a subject matter expert might be required to fulfil the role. However, access to subject matter experts might be limited and if so, the subject matter experts might need to think about how to develop model owners from the user group. With the right insight, this is possible and one way is to standardise the work for calibration models. Using appropriate tools building a calibration model should not require a PhD.
Models are dynamic entities and an obvious model lifecycle can be defined by the following stages:
Model development
Model implementation
Model use: Model monitoring; Model maintenance; Model update
Model retirement
In order to use any model in a regulated environ – ment quality (version) control is obligatory as well as plans or procedures for how to handle the models at the different stages. In companies which have invested in PAT systems (SIPAT, SynTQ etc) version control is implemented as part of the package. If such systems are not available or if the model is for an area where the PAT system is not relevant, other control solutions are required. The major analysis packages (Simca-P+, Unscrambler, GRAMS AI etc) have audit trails so it is reasonably easy to align the version control with the existing quality system for technical reports for instance. Another obvious solution is to keep track of the model versions using the quality system for laboratory methods.
The benefit of using chemometric models is dependent on what type of model is used and how it is integrated with the control strategy. If the chemometric model is part of a PAT setup to assess assays online, the benefit is related to the replacement of an effort intensive laboratory method. A secondary benefit is that the assay results become available during manufacturing allowing for immediate investigation and possible correction during manufacturing. Other models will provide other types of benefits, and in many instances, routine use of a model enables quantification of quality or performance parameters which is a first step towards real time quality control.
The most robust way for a company to take advantage of chemometrics models is to incorporate the ambitions in the overall company [site] strategy such as the QbD and PAT programme to ensure a uniform imple – mentation. In order to do this successfully a good understanding of chemometrics potential and challenges is required, but almost as important is clarity around the ambitions to ensure that they are specific and deliverable. One point to consider is that the realisation of the benefits can be separated from any upfront investments as well as being absorbed by any parallel change programs leading to a dilution of the perceived benefit. This can of course be counteracted by conscious planning of milestones and success criteria.
A more pragmatic approach to taking advantage of chemometrics is a project-toproject approach where each model is scoped, developed and implemented as a standalone project with corresponding benefit assess – ments. The risk of this approach in larger organisations is diverse and inconsistent implementation of the chemometrics solutions. On the other hand, each project will be adding value and accordingly support instigation of future projects.
There is of course no single right answer to the best approach to utilise chemometrics for all companies as ways of working and company culture are influential on what approach or combination of approaches will have the most impact. However, there are numerous examples of successful chemometrics models in daily use, within pharma and across other industries, so the starting point will be to define the ambition or problem at hand and then explore what is already out there.
About the author
Dr Geir Rune Flåten is currently an independent consultant. He recently left GlaxoSmithKline where he worked as Chemometrician Leader in Global Manufacturing and Supply (GMS) for five years. In GSK he lead a team of chemometrics subject matter experts, developed and implemented MVA strategies including quality systems for models, developed and validated novel chemometrics and PAT methods, developed and validated data analytical tools and supported new product introduction and global supply. Before joining GlaxoSmithKline, he completed a period as a postdoc in Centre for Process Analytics and Control Technology (CPACT). Dr Flåten was awarded his PhD at the University of Bergen.
This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking "I agree" you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our "Cookie Settings". Please view our Cookie Policy to learn more about the use of cookies on our website.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Cookie
Description
cookielawinfo-checkbox-advertising-targeting
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID
This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged
This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.
Performance cookies are includes cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.
Cookie
Description
cf_ob_info
This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob
This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only
This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush
This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db
This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC
This cookie is set by Youtube and is used to track the views of embedded videos.
Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.
Cookie
Description
bcookie
This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS
This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang
This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc
This cookie is set by LinkedIn and used for routing.
lissc
This cookie is set by LinkedIn share Buttons and ad tags.
vuid
We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId
This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule
This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session
This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues
This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga
This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat
This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid
This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.
Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.
Cookie
Description
advanced_ads_browser_width
This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions
This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info
This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer
This cookie is set by Advanced Ads and sets the referrer URL.
bscookie
This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE
This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr
This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory
This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE
This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.